A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE Study

COMMENTED

Asthma

Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry

★ 2 Recommended by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Biomedicines

Jaun F, Boesing M, Lüthi-Corridori G, Bridevaux PO, Charbonnier F, Clarenbach CF, Fellrath JM, Gianella P, Jochmann A, Kern L, Pavlov N, Latshang TD, Von Garnier C, Leuppi JD

doi: 10.3390/biomedicines13123074

COMMENTED

Asthma

Association Between Noninvasive Positive Pressure Ventilation Use and Clinical Outcomes During a Severe Asthma Exacerbation: A Cohort Study

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Crit Care Med

Abbott MR, Carpenter KP, Razi S, Goss CW, Buss J, Keller M, Lyons PG, Castro M, Krings JG

doi: 10.1097/CCM.0000000000007025

RECOMMENDED

Asthma

Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

★ 1 Recommended by Dr. med. Martin Frey, Faculty Member

Allergy Asthma Immunol Res

Chen R, Dai Y, Yang D, Liu C, Han W, Gu W, Cao J, Zhou Q, Howarth P, Weng S, Xiong C, Huang J, Liang P, Zhong N, 201536 Study Group

doi: 10.4168/aair.2025.17.4.473

Asthma

Long-Term Clinical and Biological Outcomes of Biologic Therapy in Severe Asthma: 24-Month Real-World Cohort Study from Romania

J Clin Med

Mărginean C, Safta AC, Huțanu D, Budin CE, Ianosi MB, Jimborean G, Ianosi ES

doi: 10.3390/jcm15062444

Asthma

Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)

Allergy Asthma Immunol Res

Sohn KH, Lee SK, Lee HY, Kim SR, Lee SE, Kim JH, Song WJ, Kim SH, Korean Severe Asthma Registry (KoSAR) Investigators

doi: 10.4168/aair.2026.18.2.192

Asthma

Adherence to Biologic Therapies is Associated with Improved Clinical Outcomes and Reduced Healthcare Resource Utilization in Patients with Severe Asthma in Japan

J Asthma Allergy

Nagase H, Karsanji U, Kunishige H, Suzuki T, Vichiendilokkul A, Yuanita L, Sasakura N, Wang J, Noibi S

doi: 10.2147/JAA.S590261

Asthma

Effectiveness of FF/UMEC/VI versus ICS/LABA in Patients with Uncontrolled Asthma Treated in Routine Clinical Practice (PERFORM): A Pragmatic Randomized Controlled Trial

J Asthma Allergy

Penz E, Noorduyn SG, Moore AC, Nagase H, Crawford J, Woessner M, Demetriou L, Brown N, Slade D, Garcia G, Baptist AP, Oppenheimer JJ

doi: 10.2147/JAA.S599766

RECOMMENDED

Asthma

Challenges in Evaluating Clinical Remission in Severe Asthma: Insights from the Mayo Clinic

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Adv Ther

Lim K, Deb A, Corbridge T, Lee L, Kelloway J, Simsek S, Manoharan M, Barman H, Wagner T

doi: 10.1007/s12325-025-03433-y

Asthma

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study

Lancet Respir Med

Logan J, Martin K, Gillespie L, McConnachie A, Lee WN, Burhan H, Brown T, Faruqi S, Jackson DJ, Kurukulaaratchy R, Mansur AH, Saralaya D, Fowler SJ, Patel P, Brown J, Lordan J, Siddiqui S, Smith SJ, Shah PA, Haldar K, Megremis S, Harrison SA, Brown R, Nelson C, Mistry V, Brown V, Chalmers JD, Djukanovic R, Pavord ID, Heaney LG, Brightling CE, Chaudhuri R

doi: 10.1016/S2213-2600(26)00096-2

Related content

Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry

Association Between Noninvasive Positive Pressure Ventilation Use and Clinical Outcomes During a Severe Asthma Exacerbation: A Cohort Study

Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

Long-Term Clinical and Biological Outcomes of Biologic Therapy in Severe Asthma: 24-Month Real-World Cohort Study from Romania

Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)

Adherence to Biologic Therapies is Associated with Improved Clinical Outcomes and Reduced Healthcare Resource Utilization in Patients with Severe Asthma in Japan

Effectiveness of FF/UMEC/VI versus ICS/LABA in Patients with Uncontrolled Asthma Treated in Routine Clinical Practice (PERFORM): A Pragmatic Randomized Controlled Trial

Challenges in Evaluating Clinical Remission in Severe Asthma: Insights from the Mayo Clinic

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study